GARDskin approved by OECD

THE FIRST AND ONLY Genomics and Machine-learning based in vitro skin sensitization assay

Get a quote

Sensitization Testing with GARD®

Regulatory Toxicity Testing

Biological Evaluation of Medical Devices

The GARD® technology: An holistic approach

Learn more about the improved accuracy and human relevance

SenzaGen provides state-of-the-art non-animal tests for assessing a substance’s allergenicity. With excellent predictivity, the tests meet needs in several industries and help companies develop, produce and deliver safer, ethical and more sustainable products.

GLP Compliant Laboratory

READ MORE

Meet Us.

SOT2023 Recap Webinar

April 26 @ 16:00 - 17:00

12th World Congress on Alternatives and Animal Use in the Life Sciences WC12

August 27 @ 08:00 - August 31 @ 17:00Niagara Falls, Canada
EVENT CALENDAR

Press Releases

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
23 Feb, 2023
News
IR
English
Corporate Information
Sales
Order
SenzaGen wins order for GARD®skin worth about SEK 1m from a new chemicals customer
16 Feb, 2023
News
IR
English
Regulatory
MAR
Report
Interim
Yearend
SenzaGen’s 2022 Year-End Report: Breakthrough for SenzaGen in both sales and technology
09 Feb, 2023
News
IR
English
Corporate Information
Presentation
Invitation to the presentation of SenzaGen’s year-end report 2022 on Feb 16 at 14.00 CET
Next

News Posts

Subscribe


Prenumerera